Incyte Corporation

Biotechnology & Medical Research

Company Summary

The biopharmaceutical business Incyte Corporation focuses on the research, development, and commercialization of patented therapies in the United States and globally. The business was founded in 1991 and is based in Wilmington, Delaware.

ESG Rating Overview

Sustainalytics

Overall ESG Rating :

23.8
Rating Scale
0-10Negligible10-20Low20-30Med30-40High40+Severe
0100E1.5S15.6G6.8

Refinitiv

Overall ESG Rating :

46
Rating Scale
0-25Poor 25-50Satisfactory 50-75Good75-100Excellent
0100E24S40G72

Overall ESG Rating :

BBB
Rating Scale
CCCB
Laggard
BBBBBA
Average
AAAAA
Leader

Incyte is average among 43 companies in the biotechnology industry.

Temperature Rise :

1.6℃
CLIMATE SCALE
≥ 3.85°CLagging > 2°C - < 3.85°CMisaligned ≤ 2°CAligned